Log in

09:24 amHUGE anti-cancer potential which has gotten very little media attention. Why? Could it be because it's a drug which already has "generic" status, and no drug maker will do clinical studies with it, as they won't make billions off of it? Or is that just a cynical point of view?

I'm a super dork, but this is so cool, "mitochondria do another job in cells: they activate apoptosis, the process by which abnormal cells self-destruct. When cells switch mitochondria off, they become “immortal”, outliving other cells in the tumour and so becoming dominant. Once reawakened by DCA, mitochondria reactivate apoptosis and order the abnormal cells to die."